SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-031268
Filing Date
2020-10-14
Accepted
2020-10-14 16:41:52
Documents
13
Period of Report
2020-10-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea128136-8k_cormedixinc.htm   iXBRL 8-K 26420
2 SECOND AMENDED AND RESTATED BYLAWS OF CORMEDIX INC ea128136ex3-1_cormedixinc.htm EX-3.1 62077
  Complete submission text file 0001213900-20-031268.txt   279671

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crmd-20201008.xsd EX-101.SCH 3176
4 XBRL LABEL FILE crmd-20201008_lab.xml EX-101.LAB 34581
5 XBRL PRESENTATION FILE crmd-20201008_pre.xml EX-101.PRE 22700
6 EXTRACTED XBRL INSTANCE DOCUMENT ea128136-8k_cormedixinc_htm.xml XML 3714
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 201239408
SIC: 2834 Pharmaceutical Preparations